
Post-Prasad, FDA Must Embrace Reform
This op-ed was originally published in the Well News. At long last, the Food and Drug Administration’s Center for Biologics Evaluation and Research Director Vinay Prasad is out. Prasad, who

This op-ed was originally published in the Well News. At long last, the Food and Drug Administration’s Center for Biologics Evaluation and Research Director Vinay Prasad is out. Prasad, who